Biotech firm Olink rises as Q3 revenue jumps
** U.S.-listed shares of Olink Holding AB OLK.O gain 3.7%
to $25.75
** Stock of the Sweden-based provider of protein analysis
products hits its highest level in ten months
** Q3 revenue rises 39% year-over-year to $44.2 mln, beating
estimates of $43.2 mln - LSEG
** Co says 54% of Q3 revenue came from its kit business
** OLK stock up 1.5% YTD, including session gains
(Reporting by Purvi Agarwal in Bengaluru)
((Purvi.Agarwal@thomsonreuters.com))
Recent news on Olink Holding AB (publ)
See all newsBrief: Olink Announces Receipt Of CMA Clearance For Proposed Acquisition By Thermo Fisher
UK's competition regulator clears $3.1 bln Thermo Fisher Scientific-Olink deal
Competition and Mkts - Merger Update : Thermo Fisher / Olink
Olink Holding AB (publ) reports results for the quarter ended in March - Earnings Summary
UK's CMA kicks off probe into Thermo Fisher-Olink deal